drugset / Trial / NCT00819312

YAZ, Oral Contraceptive Registration in China

NCT00819312

Phase 3 Completed 675 enrolled Bayer
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the effectiveness in terms of prevention of pregnancy and safety of the oral contraceptive YAZ in healthy Chinese women.

Timeline

Start
2008-12
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator drospirenone Unknown 3 mg Oral
Comparator ethinyl estradiol Small molecule 20 ug Oral

Indications

No indication recorded.